Parker Announces Retirement of Executive Chairman Thomas L. Williams and Election of Jennifer A. Parmentier as Chairman of the Board
25 oct. 2023 09h14 HE
|
Parker-Hannifin Corporation
CLEVELAND, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that its Board of Directors has elected...
AGBA Group Appoints Bob Diamond as Chairman and Announces Atlas Merchant Capital as Strategic Advisor
19 sept. 2023 09h15 HE
|
AGBA Group Holding Ltd
HONG KONG, Sept. 19, 2023 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA”, “The Group”), the leading one-stop financial supermarket in Hong Kong, announced the appointment of...
GDS NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GDS Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – GDS
21 juil. 2023 20h31 HE
|
The Rosen Law Firm PA
NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GDS Holdings Limited (NASDAQ: GDS) between April 12,...
AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman of the Board of Directors
12 juil. 2023 11h45 HE
|
AI Therapeutics, Inc.
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment...
$134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology
17 avr. 2023 08h01 HE
|
Ocean Biomedical, Inc.
Providence, RI, April 17, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (“Ocean”), a biopharma company working to accelerate the development and commercialization of scientifically compelling...
OKYO Pharma Today Announces Director Acquires Shares
30 mars 2023 02h01 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Today Announces Director Acquires Shares
29 mars 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
OKYO Pharma Announces PDMR Dealing
24 mars 2023 03h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is...
ImCheck Appoints Thomas Civik as Independent Chairman of the Board
23 mars 2023 03h00 HE
|
ImCheck Therapeutics SAS
ImCheck Appoints Thomas Civik as Independent Chairman of the Board Marseille, France, March 23, 2023 – ImCheck Therapeutics announced today the appointment of Thomas Civik as independent...
Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
21 mars 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of...